Further Implications of Off-Label Use of Acetazolamide in the Management of Moyamoya Disease in Japan: Response. (Q50139961)
Jump to navigation
Jump to search
scientific article published in July 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Further Implications of Off-Label Use of Acetazolamide in the Management of Moyamoya Disease in Japan: Response. |
scientific article published in July 2017 |
Statements
1 reference
Further Implications of Off-Label Use of Acetazolamide in the Management of Moyamoya Disease in Japan: Response. (English)
1 reference
Frederik Barkhof
1 reference
Sven Haller
1 reference
David Thomas
1 reference
Karl-Olof Lovblad
1 reference
Xavier Golay
1 reference
Greg Zaharchuk
1 reference
1 July 2017
1 reference
1 reference
284
1 reference
1
1 reference
301-303
1 reference
Identifiers
1 reference
1 reference